In diabetic nephropathy patients, the expression level of MSTN in renal tubules is increased, and MSTN induced the release of ROS and up-regulation of NADPH oxidase in cells through the ERK pathway, thus aggravate the progression of tubule cell fibrosis (72). Here, MSTN is linked to diabetic kidney disease.